Literature DB >> 17211424

Technology insight: will systems pathology replace the pathologist?

Olivier Saidi1, Carlos Cordon-Cardo, Jose Costa.   

Abstract

By using systems pathology, it might be possible to provide a predictive, personalized therapeutic recommendation for patients with prostate cancer. Systems pathology integrates quantitative data and information from many sources to generate a reliable prediction of the expected natural course of the disease and response to different therapeutic options. In other words, through the integration of relatively large data sets and the use of knowledge engineering, systems pathology aims at predicting the future behavior of tumors and their interaction with the host. In this Review, we introduce the methods used in systems pathology and summarize a recent study providing the first evidence of a concept for this strategy. The results show that systems pathology can provide a personalized prediction of the risk of recurrence after prostatectomy for cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17211424     DOI: 10.1038/ncpuro0669

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  9 in total

Review 1.  Systems pathology: a critical review.

Authors:  Jose Costa
Journal:  Mol Oncol       Date:  2011-11-27       Impact factor: 6.603

Review 2.  Systems pathology--or how to solve the complex problem of predictive pathology.

Authors:  Manfred Dietel; Reinhold Schäfer
Journal:  Virchows Arch       Date:  2008-09-13       Impact factor: 4.064

Review 3.  Combining targeted therapies: practical issues to consider at the bench and bedside.

Authors:  Jordi Rodon; Jose Perez; Razelle Kurzrock
Journal:  Oncologist       Date:  2010-01-15

4.  Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.

Authors:  Amita Shukla-Dave; Hedvig Hricak; Nicole Ishill; Chaya S Moskowitz; Marija Drobnjak; Victor E Reuter; Kristen L Zakian; Peter T Scardino; Carlos Cordon-Cardo
Journal:  Clin Cancer Res       Date:  2009-05-12       Impact factor: 12.531

5.  Improved prediction of prostate cancer recurrence through systems pathology.

Authors:  Carlos Cordon-Cardo; Angeliki Kotsianti; David A Verbel; Mikhail Teverovskiy; Paola Capodieci; Stefan Hamann; Yusuf Jeffers; Mark Clayton; Faysal Elkhettabi; Faisal M Khan; Marina Sapir; Valentina Bayer-Zubek; Yevgen Vengrenyuk; Stephen Fogarsi; Olivier Saidi; Victor E Reuter; Howard I Scher; Michael W Kattan; Fernando J Bianco; Thomas M Wheeler; Gustavo E Ayala; Peter T Scardino; Michael J Donovan
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

6.  Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.

Authors:  Amita Shukla-Dave; Hedvig Hricak; Nicole M Ishill; Chaya S Moskowitz; Marija Drobnjak; Victor E Reuter; Kristen L Zakian; Peter T Scardino; Carlos Cordon-Cardo
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

7.  Computer-aided detection of prostate cancer on tissue sections.

Authors:  Yahui Peng; Yulei Jiang; Shang-Tian Chuang; Ximing J Yang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-10

Review 8.  Toward Systems Pathology for PTEN Diagnostics.

Authors:  Nahal Haddadi; Glena Travis; Najah T Nassif; Ann M Simpson; Deborah J Marsh
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

9.  Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer.

Authors:  Pere Puig; Nadina Erill; Marta Terricabras; Isaac Subirana; Judit González-García; Adrià Asensi-Puig; Michael J Donovan; Lourdes Mengual; M Teresa Agulló-Ortuño; Mireia Olivan; Antonio Alcaraz; José A López-Martín; Inés de Torres; José Luis Rodríguez-Peralto; Alfredo Rodríguez-Antolín; Juan Morote; Víctor González-Rumayor
Journal:  BMC Res Notes       Date:  2019-01-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.